Zobrazeno 1 - 3
of 3
pro vyhledávání: '"SA Revilla"'
Autor:
Trudy G. N. Jonges, LM van Wijk, Mpg Vreeswijk, Hans Clevers, Kadi Lõhmussaar, MJ van Roosmalen, M van de Ven, Johannes L. Bos, A van Oudenaarden, Oded Kopper, Nizar Hami, SA Revilla, Vwh Ho, Harry Begthel, Hjg Snippert, Wigard P. Kloosterman, J Espejo Valle-Inclan, Petronella O. Witteveen, P. J. Van Diest, Katja N. Gaarenstroom, Benjamin G. Neel, Harry Vrieling, Ronald P. Zweemer, Lennart Kester, Jeroen Korving, Tjalling Bosse, Natalie Proost, R Theeuwsen, Bas Ponsioen, CJ de Witte, Anjali Vanita Balgobind
Publikováno v:
Poster exhibition Day 2.
Introduction/Background Ovarian cancer (OC) is a heterogeneous disease usually diagnosed at a late stage. Experimental in vitro models that faithfully capture the hallmarks and tumour heterogeneity of OC are limited and hard to establish. Methodology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57deabb996bdd1e521499647df9b82c0
https://doi.org/10.1136/ijgc-2019-esgo.182
https://doi.org/10.1136/ijgc-2019-esgo.182
Autor:
Kopper O; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., de Witte CJ; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Lõhmussaar K; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Valle-Inclan JE; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Hami N; Oncode Institute, Utrecht, the Netherlands.; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Kester L; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Balgobind AV; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Korving J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Proost N; Preclinical Intervention Unit of the Mouse Clinic for Cancer and Ageing (MCCA) at the NKI, Amsterdam, the Netherlands., Begthel H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Wijk LM; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., Revilla SA; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Theeuwsen R; Preclinical Intervention Unit of the Mouse Clinic for Cancer and Ageing (MCCA) at the NKI, Amsterdam, the Netherlands., van de Ven M; Preclinical Intervention Unit of the Mouse Clinic for Cancer and Ageing (MCCA) at the NKI, Amsterdam, the Netherlands., van Roosmalen MJ; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Ponsioen B; Oncode Institute, Utrecht, the Netherlands.; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Ho VWH; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada., Neel BG; Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Bosse T; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Gaarenstroom KN; Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands., Vrieling H; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Witteveen PO; Department of Medical Oncology, Cancer Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Jonges T; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Bos JL; Oncode Institute, Utrecht, the Netherlands.; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Oudenaarden A; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zweemer RP; Department of Gynaecological Oncology, Cancer Center, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Snippert HJG; Oncode Institute, Utrecht, the Netherlands.; Molecular Cancer Research, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Kloosterman WP; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. w.kloosterman@umcutrecht.nl., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and UMC Utrecht, Utrecht, the Netherlands. h.clevers@hubrecht.eu.; Oncode Institute, Utrecht, the Netherlands. h.clevers@hubrecht.eu.; The Netherlands Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. h.clevers@hubrecht.eu.
Publikováno v:
Nature medicine [Nat Med] 2019 May; Vol. 25 (5), pp. 838-849. Date of Electronic Publication: 2019 Apr 22.
Autor:
Lopes R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Korkmaz G; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Revilla SA; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Vliet R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Nagel R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Custers L; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Kim Y; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Breugel PC; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Moumbeini B; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Manber Z; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel., Elkon R; Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, 69978, Israel., Agami R; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Molecular Genetics, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands. Electronic address: r.agami@nki.nl.
Publikováno v:
Cancer letters [Cancer Lett] 2018 Nov 01; Vol. 436, pp. 87-95. Date of Electronic Publication: 2018 Aug 23.